Welcome to the stock market today! As we head into the weekend, the novel coronavirus remains top of mind. Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have filed for emergency-use authorization. Will that step give investors some confidence? Maybe not. We also learned Friday that the World Health Organization is knocking Gilead (NASDAQ:GILD) down a peg, causing
Daily Trade
On June 1, DraftKings (NASDAQ:DKNG) closed at $43.70. This Monday, DraftKings stock closed about 2% lower. Source: Lori Butcher / Shutterstock.com That trading is somewhat interesting given what’s transpired over those five and a half months. Pretty much everything has gone right for DraftKings. The external environment has steadily improved. And yet, DraftKings stock has
Fisker (NYSE:FSR) is one of the hottest stocks in the red-hot electric vehicle (EV) sector. If you were an investor when the stock began publicly trading, you’ve seen the value of your investment nearly double (as of this writing). Source: Scharfsinn / Shutterstock.com Too far too fast? That remains to be seen. However, at some
2020 will be remembered as the year of many things, most of which we’d probably just as soon forget. Source: Shutterstock But from an investing standpoint, we may well look back on 2020 as the year of the SPAC. We’ve talked about SPACs before. It’s an acronym for Special Purpose Acquisition Company, which is a
Sundial Growers (NASDAQ:SNDL) reported its third-quarter results on Nov. 11. Hidden among the various financial details was a note that the company plans to consolidate Sundial Growers stock to remain in compliance with Nasdaq listing standards. Source: Shutterstock Trading at 25 cents as I write this, it will most likely have to do a reverse
For months, electric vehicle (EV) investors have eagerly anticipated the special acquisition company (SPAC) listing of Fisker (NYSE:FSR), a clean-auto company founded by famed car designer Henrik Fisker. Now those investors have been well-rewarded — FSR stock has already risen over 65% since its went public on Oct. 30. Source: Eric Broder Van Dyke /
Less than two months into life as a public company, Palantir Technologies (NYSE:PLTR) is proving investors love the shiny new object when it comes to data infrastructure and technology fare. PLTR stock is already up nearly 68% since its Sept. 30 initial public offering (IPO). Source: Sundry Photography / Shutterstock.com Colorado-based Palantir is classified as
I will start with the conclusion, then work backwards into it. Investors can own Southwest (NYSE:LUV) stock for the long haul recovery. Shorter term, I would prefer to buy it on the dip towards $40. Last week’s Pfizer (NYSE:PFE) headline spike placed resistance above, so it will be a slog for a few weeks. Case
Somehow, it just feels odd to write an analysis of a company with the mighty seafarin’ name of Ocean Power Technologies (NASDAQ:OPTT) when its OPTT stock has a price befitting a kiddie pool: $1.67 per share. This, as you may well know, is penny stock territory and tossing pennies in a fountain (or the “Ocean”
When I last wrote about Sorrento Therapeutics (NASDAQ:SRNE) in early October, it was trading around $11.20, well down from its all-time high of $19.39, still up significantly from where it started the year. Source: Shutterstock At the time, I suggested that Sorrento was a better buy in the single digits. Now trading around $6 as
JFrog (FROG) just released its first quarterly earnings report as a publicly traded company. Mid-September, I wondered if this ”liquid software” play was demonstrating on impressive enough performance on the day it went public. Judging by the trading action since the public offering, investors have held good believe in the prospects for the company, yet
In the spring, British multinational oil and gas giant BP PLC (NYSE:BP) was teetering. Walloped by an oil price war, slammed by a precipitous drop in demand thanks to the novel coronavirus pandemic, then caught up in a stock market crash, BP stock fell off a cliff. Source: JuliusKielaitis / Shutterstock.com After a brief post-crash
Animal lovers, unite! Zomedica Pharmaceuticals (NYSEMKT:ZOM), an under-the-radar play on the pet care space, is having an impressive time in the stock market today. In fact, one big catalyst has ZOM stock up more than 20% today. Source: Shutterstock So what exactly is Zomedica Pharmaceuticals? And what is that big catalyst? Starting with the first
Some folks won’t be old enough to recall a time when Kodak (NYSE:KODK) was known for selling non-digital cameras. In 2020, the year of the novel coronavirus pandemic, the company is radically different, and traders think of Kodak stock as a “coronavirus stock.” Source: Katherine Welles / Shutterstock.com When a company has been entrenched in one
It was a quiet day in the stock market, despite the S&P 500 rallying more than 1%. Investors are still waiting for tech to regain its footing and find some momentum. Let’s look at a few top stock trades ahead of next week. Top Stock Trades for Tomorrow No. 1: Nio (NIO) Nio (NASDAQ:NIO) has
This has been one of the craziest weeks I can remember in more than 20 years. Source: Shutterstock I already told you how Monday was one of the strangest trading days I’ve ever experienced. And while the rest of the week wasn’t quite as wacky, it was certainly different. One theme was a rotation out
Trading at a low valuation, especially for a growing company in the tech sector, McAfee (NYSE:MCFE) has some significant, positive attributes. Nonetheless, I advise investors to wait until after the company reports its third-quarter results before buying MCFE stock. Source: Tada Images / Shutterstock.com McAfee has outstanding products, a high number of customers, a strong
The stock market is consolidating today following its big rally on Monday, which saw the S&P 500 and Dow surge to new record highs on massive volume. As I said in Tuesday’s Market360, the rally was a “mean reversion” rally and a big shift out of growth and into value. Source: Michael Vi / Shutterstock.com The good
The media likes to focus on Zoom Video (NASDAQ:ZM) as its poster child of a novel coronavirus stock winner. But Overstock.com (NASDAQ:OSTK) has quietly eclipsed the tech platform’s shares, with OSTK stock rising more than six-fold year-to-date, 40% more than Zoom. Source: Burdun Iliya / Shutterstock.com Unfortunately, that’s not any consolation to recently buyers. OSTK
From a bird’s-eye view, DraftKings (NASDAQ:DKNG) is a name that you’ll want to own for the long haul. With sports returning back to the forefront after the novel coronavirus initially disrupted major professional leagues, DKNG stock has clear upside ahead, and a growing consumer base to boot. Source: Lori Butcher/Shutterstock.com According to data from The